Entries by Rebecca Mercer

Early HTA Funding Opportunity – BioCanRx

Additional details about how you can apply to this program can be found online at https://biocanrx.com/research/research-program/research-funding/application-process-and-instructions *TARGETED FUNDING CALL: BioCanRx is pleased to announce that the next call for applications is now open in the Clinical, Social & Economic Impact (CSEI) program. At this time, BioCanRx is placing highest priority on the intake (more…)

Scientist – Cancer Care Manitoba

Research Institute in Oncology and Hematology A Joint Institute of CancerCare Manitoba and University of Manitoba Term, Full-Time (1.0 EFT) October 2, 2017 – October 1, 2018 Competition #: 107-17-761020300 Research Institute in Oncology and Hematology invites applications for a full-time position as a Scientist and the appropriate level of (more…)

CanREValue: Developing a Framework for the Incorporation of Real World Evidence into Cancer Drug Funding Decisions in Canada

  Lead Investigator(s): Kelvin Chan, Stuart Peacock, Wanrudee Isaranuwatchai, Mina Tadrous, Michael Sherar Lead Institution: Sunnybrook Research Institute Co-Investigators: Riaz Alvi, Jaclyn Beca, Yvonne Bombard, Melissa Brouwers, Winson Cheung, Janet Dancey, Claire de Oliveira, Craig Earle, Jeffrey Hoch, Robin McLeod, Nicole Mittmann, Petros Pechlivanoglou, Eleanor Pullenayegum, Maureen Trudeau, ARCC Program (more…)

Manager, Knowledge Mobilization Strategy, Canadian Partnership Against Cancer

Position: Manager, Knowledge Mobilization Strategy Reports to:  Director, Knowledge Mobilization Location: Toronto (Downtown) Status: Full-Time Posting date: June 9, 2017 Closing Date: June 26, 2017 Overview of Role: Reporting to the Director, Knowledge Mobilization, the Manager, Knowledge Mobilization Strategy is accountable for driving and implementing a strategy for the effective (more…)

A qualitative evaluation of patient engagement in the pan-Canadian Oncology Drug Review process – Part 2: Patient group perspectives

Lead Investigator(s): Kelvin Chan Lead Institution: Sunnybrook Research Institute Co-Investigators: Alexandra Chambers, Helen Mai, Linda Rozmovits ARCC Program Area(s): Health Technology Assessment Funding Term: 2017-2018 Patient input into drug funding reviews by Health Technology Assessment (HTA) agencies is essential to ensuring that patient perspectives inform decision-making about drug reimbursement in (more…)